The utility of biomarkers to predict steroid response in idiopathic nephrotic syndrome
Objective: The most common form of nephrotic syndrome (NS) is minimal change disease (MCD) in children and focal segmental glomerulosclerosis (FSGS) following it. As, it is important to predict corticosteroid (CS) response at the beginning of the disease, we aimed to evaluate the efficacy of some bi...
Gespeichert in:
Veröffentlicht in: | Marmara Medical Journal 2024-10, Vol.37 (3), p.295-299 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 299 |
---|---|
container_issue | 3 |
container_start_page | 295 |
container_title | Marmara Medical Journal |
container_volume | 37 |
creator | Çiçek, Neslihan Gökçe, İbrahim Güven, Serçin Yaman, Ali Alpay, Harika |
description | Objective: The most common form of nephrotic syndrome (NS) is minimal change disease (MCD) in children and focal segmental glomerulosclerosis (FSGS) following it. As, it is important to predict corticosteroid (CS) response at the beginning of the disease, we aimed to evaluate the efficacy of some biomarkers in terms of predicting steroid response in patients with NS. Patients and Methods: Twenty patients who met the inclusion criteria for the study were divided into 3 groups and 6 healthy control participants were included in the analysis as the 4th group. Group-1 included 10 patients at the first episode of idiopathic NS (INS), group-2 included the same 10 patients in remission, group-3 included 10 patients with steroid resistant NS (SRNS) diagnosed as FSGS by renal biopsy, and group-4 included six healthy children as controls. Urinary and serum cluster of differentiation (CD) CD80, IL-17, IL-23, IL-10, TGF-β, CD86, CD28, CTLA-4 levels were measured for all groups. Results: Urinary CD80 level in INS-relapse group was significantly higher than the levels of the INS-remission, FSGS and control groups (p |
doi_str_mv | 10.5472/marumj.1571937 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3128523054</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3128523054</sourcerecordid><originalsourceid>FETCH-LOGICAL-c674-b37f328b4729ed6213cf214df886152a8d409f9bbcdc9727121e1bed1f62bf343</originalsourceid><addsrcrecordid>eNotkL1PwzAUxC0EEqWwMltiTvGznTgeUcWXVImlYrUS-1l1aeNgO0P_e4La6W443Xv3I-QR2KqWij8fuzQd9yuoFWihrsgCBNOVlo2-nj0DXYGWcEvuct4zVrdMNwvyvd0hnUo4hHKi0dM-xLnnB1OmJdIxoQu20FwwxeBowjzGISMNAw0uxLEru2DpgOMuxTK7fBpcike8Jze-O2R8uOiSbN9et-uPavP1_rl-2VS2UbLqhfKCt_38vUbXcBDWc5DOt20DNe9aJ5n2uu-ts1pxBRwQenTgG957IcWSPJ1rxxR_J8zF7OOUhvmiEcDbmgtW_6dW55RNMeeE3owpzCtPBpj5R2fO6MwFnfgDtv5kGQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3128523054</pqid></control><display><type>article</type><title>The utility of biomarkers to predict steroid response in idiopathic nephrotic syndrome</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Çiçek, Neslihan ; Gökçe, İbrahim ; Güven, Serçin ; Yaman, Ali ; Alpay, Harika</creator><creatorcontrib>Çiçek, Neslihan ; Gökçe, İbrahim ; Güven, Serçin ; Yaman, Ali ; Alpay, Harika</creatorcontrib><description>Objective: The most common form of nephrotic syndrome (NS) is minimal change disease (MCD) in children and focal segmental glomerulosclerosis (FSGS) following it. As, it is important to predict corticosteroid (CS) response at the beginning of the disease, we aimed to evaluate the efficacy of some biomarkers in terms of predicting steroid response in patients with NS. Patients and Methods: Twenty patients who met the inclusion criteria for the study were divided into 3 groups and 6 healthy control participants were included in the analysis as the 4th group. Group-1 included 10 patients at the first episode of idiopathic NS (INS), group-2 included the same 10 patients in remission, group-3 included 10 patients with steroid resistant NS (SRNS) diagnosed as FSGS by renal biopsy, and group-4 included six healthy children as controls. Urinary and serum cluster of differentiation (CD) CD80, IL-17, IL-23, IL-10, TGF-β, CD86, CD28, CTLA-4 levels were measured for all groups. Results: Urinary CD80 level in INS-relapse group was significantly higher than the levels of the INS-remission, FSGS and control groups (p</description><identifier>ISSN: 1019-1941</identifier><identifier>EISSN: 1309-9469</identifier><identifier>DOI: 10.5472/marumj.1571937</identifier><language>eng</language><publisher>Istanbul: Marmara University</publisher><subject>Biomarkers ; Kidney diseases ; Remission (Medicine) ; Steroids</subject><ispartof>Marmara Medical Journal, 2024-10, Vol.37 (3), p.295-299</ispartof><rights>2024. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://dergipark.org.tr/en/pub/marumj/about-journal</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c674-b37f328b4729ed6213cf214df886152a8d409f9bbcdc9727121e1bed1f62bf343</cites><orcidid>0000-0002-6896-5162 ; 0000-0003-3284-9204 ; 0000-0002-5859-4177 ; 0000-0001-5659-5195 ; 0000-0002-0850-1964</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Çiçek, Neslihan</creatorcontrib><creatorcontrib>Gökçe, İbrahim</creatorcontrib><creatorcontrib>Güven, Serçin</creatorcontrib><creatorcontrib>Yaman, Ali</creatorcontrib><creatorcontrib>Alpay, Harika</creatorcontrib><title>The utility of biomarkers to predict steroid response in idiopathic nephrotic syndrome</title><title>Marmara Medical Journal</title><description>Objective: The most common form of nephrotic syndrome (NS) is minimal change disease (MCD) in children and focal segmental glomerulosclerosis (FSGS) following it. As, it is important to predict corticosteroid (CS) response at the beginning of the disease, we aimed to evaluate the efficacy of some biomarkers in terms of predicting steroid response in patients with NS. Patients and Methods: Twenty patients who met the inclusion criteria for the study were divided into 3 groups and 6 healthy control participants were included in the analysis as the 4th group. Group-1 included 10 patients at the first episode of idiopathic NS (INS), group-2 included the same 10 patients in remission, group-3 included 10 patients with steroid resistant NS (SRNS) diagnosed as FSGS by renal biopsy, and group-4 included six healthy children as controls. Urinary and serum cluster of differentiation (CD) CD80, IL-17, IL-23, IL-10, TGF-β, CD86, CD28, CTLA-4 levels were measured for all groups. Results: Urinary CD80 level in INS-relapse group was significantly higher than the levels of the INS-remission, FSGS and control groups (p</description><subject>Biomarkers</subject><subject>Kidney diseases</subject><subject>Remission (Medicine)</subject><subject>Steroids</subject><issn>1019-1941</issn><issn>1309-9469</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNotkL1PwzAUxC0EEqWwMltiTvGznTgeUcWXVImlYrUS-1l1aeNgO0P_e4La6W443Xv3I-QR2KqWij8fuzQd9yuoFWihrsgCBNOVlo2-nj0DXYGWcEvuct4zVrdMNwvyvd0hnUo4hHKi0dM-xLnnB1OmJdIxoQu20FwwxeBowjzGISMNAw0uxLEru2DpgOMuxTK7fBpcike8Jze-O2R8uOiSbN9et-uPavP1_rl-2VS2UbLqhfKCt_38vUbXcBDWc5DOt20DNe9aJ5n2uu-ts1pxBRwQenTgG957IcWSPJ1rxxR_J8zF7OOUhvmiEcDbmgtW_6dW55RNMeeE3owpzCtPBpj5R2fO6MwFnfgDtv5kGQ</recordid><startdate>20241030</startdate><enddate>20241030</enddate><creator>Çiçek, Neslihan</creator><creator>Gökçe, İbrahim</creator><creator>Güven, Serçin</creator><creator>Yaman, Ali</creator><creator>Alpay, Harika</creator><general>Marmara University</general><scope>AAYXX</scope><scope>CITATION</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><orcidid>https://orcid.org/0000-0002-6896-5162</orcidid><orcidid>https://orcid.org/0000-0003-3284-9204</orcidid><orcidid>https://orcid.org/0000-0002-5859-4177</orcidid><orcidid>https://orcid.org/0000-0001-5659-5195</orcidid><orcidid>https://orcid.org/0000-0002-0850-1964</orcidid></search><sort><creationdate>20241030</creationdate><title>The utility of biomarkers to predict steroid response in idiopathic nephrotic syndrome</title><author>Çiçek, Neslihan ; Gökçe, İbrahim ; Güven, Serçin ; Yaman, Ali ; Alpay, Harika</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c674-b37f328b4729ed6213cf214df886152a8d409f9bbcdc9727121e1bed1f62bf343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biomarkers</topic><topic>Kidney diseases</topic><topic>Remission (Medicine)</topic><topic>Steroids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Çiçek, Neslihan</creatorcontrib><creatorcontrib>Gökçe, İbrahim</creatorcontrib><creatorcontrib>Güven, Serçin</creatorcontrib><creatorcontrib>Yaman, Ali</creatorcontrib><creatorcontrib>Alpay, Harika</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Marmara Medical Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Çiçek, Neslihan</au><au>Gökçe, İbrahim</au><au>Güven, Serçin</au><au>Yaman, Ali</au><au>Alpay, Harika</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The utility of biomarkers to predict steroid response in idiopathic nephrotic syndrome</atitle><jtitle>Marmara Medical Journal</jtitle><date>2024-10-30</date><risdate>2024</risdate><volume>37</volume><issue>3</issue><spage>295</spage><epage>299</epage><pages>295-299</pages><issn>1019-1941</issn><eissn>1309-9469</eissn><abstract>Objective: The most common form of nephrotic syndrome (NS) is minimal change disease (MCD) in children and focal segmental glomerulosclerosis (FSGS) following it. As, it is important to predict corticosteroid (CS) response at the beginning of the disease, we aimed to evaluate the efficacy of some biomarkers in terms of predicting steroid response in patients with NS. Patients and Methods: Twenty patients who met the inclusion criteria for the study were divided into 3 groups and 6 healthy control participants were included in the analysis as the 4th group. Group-1 included 10 patients at the first episode of idiopathic NS (INS), group-2 included the same 10 patients in remission, group-3 included 10 patients with steroid resistant NS (SRNS) diagnosed as FSGS by renal biopsy, and group-4 included six healthy children as controls. Urinary and serum cluster of differentiation (CD) CD80, IL-17, IL-23, IL-10, TGF-β, CD86, CD28, CTLA-4 levels were measured for all groups. Results: Urinary CD80 level in INS-relapse group was significantly higher than the levels of the INS-remission, FSGS and control groups (p</abstract><cop>Istanbul</cop><pub>Marmara University</pub><doi>10.5472/marumj.1571937</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-6896-5162</orcidid><orcidid>https://orcid.org/0000-0003-3284-9204</orcidid><orcidid>https://orcid.org/0000-0002-5859-4177</orcidid><orcidid>https://orcid.org/0000-0001-5659-5195</orcidid><orcidid>https://orcid.org/0000-0002-0850-1964</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1019-1941 |
ispartof | Marmara Medical Journal, 2024-10, Vol.37 (3), p.295-299 |
issn | 1019-1941 1309-9469 |
language | eng |
recordid | cdi_proquest_journals_3128523054 |
source | EZB-FREE-00999 freely available EZB journals |
subjects | Biomarkers Kidney diseases Remission (Medicine) Steroids |
title | The utility of biomarkers to predict steroid response in idiopathic nephrotic syndrome |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T09%3A49%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20utility%20of%20biomarkers%20to%20predict%20steroid%20response%20in%20idiopathic%20nephrotic%20syndrome&rft.jtitle=Marmara%20Medical%20Journal&rft.au=%C3%87i%C3%A7ek,%20Neslihan&rft.date=2024-10-30&rft.volume=37&rft.issue=3&rft.spage=295&rft.epage=299&rft.pages=295-299&rft.issn=1019-1941&rft.eissn=1309-9469&rft_id=info:doi/10.5472/marumj.1571937&rft_dat=%3Cproquest_cross%3E3128523054%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3128523054&rft_id=info:pmid/&rfr_iscdi=true |